
Tag: investing in Auxly Cannabis


Auxly Announces Closing of $20 Million Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

Auxly’s Subsidiary KGK Science Receives Institutional Cannabis Research Licence from Health Canada

IIROC Trading Halt – XLY

Auxly Announces $10 Million Bought-Deal Public Offering

High-Potency, Plant-Based Wellness: Dosecann Introduces Cannabis Capsules With Omega-Rich Ahiflower® Oil, A Truly Differentiated Product for the Wellness Consumer

Delta 9 Enters Into Agreement to Acquire Saskatchewan Retail Cannabis Store

Auxly’s Subsidiary KGK Science Receives Research Licence to Conduct Product Palatability and Sensory Testing with Human Subjects
